Skip to main content
Year archive

EMVISION MEDICAL DEVICES LTD — 2019 filings

All 37 regulatory filings released by EMVISION MEDICAL DEVICES LTD (EMV) in 2019, sourced directly from the official regulator.

37 Filings
2019 Period
2019 filings (37)
Filing Released Lang
Entry Into Clinic Achieved 3 pages 163.1KB
Regulatory Filings
2019-12-18 English
Amended Constitution 64 pages 569.4KB
Governance Information
2019-12-03 English
AGM Address & Presentation 12 pages 1.6MB
AGM Information
2019-11-25 English
Results of Annual General Meeting 1 page 193.6KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-25 English
Appendix 3B & Cleansing Notice 15 pages 491.1KB
Share Issue/Capital Change
2019-11-12 English
EMVision Completes $4.5M Placement 2 pages 146.9KB
Capital/Financing Update
2019-11-04 English
Trading Halt 2 pages 238.6KB
Capital/Financing Update
2019-10-31 English
EMVision Completes First Clinical Unit Targeting Stroke 3 pages 4.8MB
Regulatory Filings
2019-10-30 English
Appendix 4C - quarterly 8 pages 310.9KB
Interim / Quarterly Report
2019-10-30 English
Notice of Annual General Meeting/Proxy Form 20 pages 624.6KB
AGM Information
2019-10-24 English
Pause In Trading 1 page 111.1KB
Regulatory Filings
2019-10-08 English
Trading Halt 1 page 75.2KB
Regulatory Filings
2019-10-08 English
Trading Halt Request 1 page 133.4KB
Regulatory Filings
2019-10-08 English
Response to ASX Price Query 3 pages 276.0KB
Regulatory Filings
2019-10-08 English
On Target For Trial To Commence Q4 Calendar 2019 3 pages 615.2KB
Capital/Financing Update
2019-09-02 English
Appendix 4E & Annual Report 30 June 2019 48 pages 1.1MB
Annual Report
2019-08-29 English
Appendix 4G & Corporate Governance Statement 22 pages 375.3KB
Regulatory Filings
2019-08-29 English
Investor Presentation 22 pages 2.5MB
Investor Presentation
2019-07-24 English
Bioshares Biotech Summit Presentation 19 pages 2.2MB
Investor Presentation
2019-07-24 English
Appendix 4C - quarterly 8 pages 274.6KB
Interim / Quarterly Report
2019-07-22 English
Release of Restricted Securities from Escrow 1 page
Capital/Financing Update
2019-07-07 English
Appendix 3B 13 pages 301.9KB
Capital/Financing Update
2019-07-04 English
EMvision Appoints Head of Quality & Regulatory Affairs 2 pages 165.4KB
Board/Management Information
2019-07-02 English
Brain Scanner Development Update 4 pages 399.5KB
Investor Presentation
2019-06-30 English
EMvision Appoints Clinical Advisory Board 4 pages 389.4KB
Board/Management Information
2019-06-11 English
Change of Director's Interest Notice 3 pages 184.1KB
Director's Dealing
2019-06-04 English
Australian Stoke Alliance Successful in Frontiers Bid 2 pages 144.7KB
Regulatory Filings
2019-05-21 English
Strategic Collaboration with Keysight Technologies 4 pages 695.1KB
Capital/Financing Update
2019-04-29 English
Appendix 3B Release of Restricted Securities 13 pages 262.9KB
Share Issue/Capital Change
2019-04-29 English
Appendix 4C - quarterly 8 pages 273.1KB
Interim / Quarterly Report
2019-04-14 English
Release of Restricted Securities from Escrow 2 pages 148.3KB
Capital/Financing Update
2019-04-09 English
EMvision Secures Ethics Approval for Pilot Clinical Trial 2 pages 426.0KB
Regulatory Filings
2019-03-26 English
EMvision Invited to Join Australian Stroke Alliance 2 pages 198.0KB
Regulatory Filings
2019-03-17 English
Half Yearly Report and Accounts 17 pages 453.2KB
Interim / Quarterly Report
2019-02-25 English
Investor Presentation 22 pages 12.5MB
Investor Presentation
2019-02-04 English
Appendix 4C - quarterly 8 pages 311.2KB
Interim / Quarterly Report
2019-01-29 English
Positive Safety Observations from Healthy Human Trials 2 pages 192.0KB
Regulatory Filings
2019-01-23 English